• 中国核心期刊(遴选)数据库收录期刊
  • 中文科技期刊数据库收录期刊
  • 中国期刊全文数据库收录期刊
  • 中国学术期刊综合评价数据库统计源期刊等

快速检索引用检索图表检索高级检索

中国医药导刊 ›› 2021, Vol. 23 ›› Issue (3): 199-202.

• 临床药学 • 上一篇    下一篇

通塞脉胶囊联合介入手术治疗糖尿病足的临床研究

袁向科1, 江瑞2   

  1. 1. 河南省中医院, 河南 郑州 450002;
    2. 河南中医药大学第三附属医院, 河南 郑州 450006
  • 收稿日期:2020-08-11 修回日期:2021-02-09 出版日期:2021-03-28 发布日期:2021-03-28
  • 基金资助:
    河南省中医药科学研究专项课题(项目编号:20-21ZY2202;项目名称:糖尿病足溃疡病原菌调查及中药外治的临床研究)

Clinical Study of Tongsaimai Capsules Combined with Interventional Surgery in the Treatment of Diabetic Foot

YUAN Xiangke1, JIANG Rui2   

  1. 1. Henan Province Hospital of Ttraditional Chinese Medicine, Henan Zhengzhou 450002, China;
    2. The Third Affiliated Hospital of Henan University of Chinese Medicine, Henan Zhengzhou 450006, China
  • Received:2020-08-11 Revised:2021-02-09 Online:2021-03-28 Published:2021-03-28

摘要: 目的:观察通塞脉胶囊联合介入手术治疗糖尿病足的临床疗效。方法:80例糖尿病足患者随机分为对照组和观察组,各40例。对照组给予介入手术,观察组给予通塞脉胶囊联合介入手术。治疗前及术后3个月观察两组患者血清炎症因子[肿瘤坏死因子α(TNF-α)、白细胞介素6(IL-6)],血糖指标[空腹血糖(FPG),餐后 2 h血糖(2hPG)],足背动脉血流动力学(动脉内径、动脉血流速度)。结果:观察组治疗总有效率97.5%(39/40),高于对照组的82.5%(33/40),差异有统计学意义(P<0.05)。与对照组术后3个月比较,观察组患者血清TNF-α、IL-6、FPG、2hPG降低更明显,动脉内径、动脉血流速度增加更明显,差异均有统计学意义(P<0.05)。两组患者并发症发生率差异无统计学意义(P>0.05)。结论:通塞脉胶囊联合介入手术治疗可有效改善糖尿病足患者的血清炎症因子水平、血糖指标、足背动脉血流动力学。

关键词: font-size:medium, ">通塞脉胶囊;介入手术;糖尿病足;临床研究

Abstract: Objective: To observe the clinical efficacy of Tongsaimai capsules combined with interventional surgery in the treatment of diabetic foot. Methods: 80 patients with diabetic foot were randomly divided into the control group and the observation group, 40 cases in each group. The control group was given interventional surgery, and the observation group was given Tongsaimai capsules after interventional surgery. Serum inflammatory factors [tumor necrosis factor-α(TNF-α), interleukin-6 (IL-6)], blood glucose indicators [fasting blood glucose (FPG), 2 h postprandial blood glucose (2hPG)], and hemodynamics of dorsal foot artery (arterial diameter, arterial blood flow velocity) were observed in the two groups. Results: The total effective rate was 97.5% (39/40) in the observation group, which was higher than 82.5% (33/40) in the control group (P<0.05). Compared with the control group 3 months after surgery, TNF-α, IL-6, FPG and 2hPG in the observation group reduced more obviously than those in the control group (P<0.05), and arterial diameter and arterial blood flow velocity increased more obviously than those in the control group (P<0.05). There was no statistical difference in the incidence of complications between the two groups (P>0.05). Conclusion: Tongsaimai capsules combined with interventional surgery can effectively improve the level of inflammatory factors, blood glucose indicators, and hemodynamics of dorsal foot artery of diabetic foot patients.

Key words: font-size:medium, ">Tongsaimai capsules; Interventional surgery; Diabetic foot; Clinical research

中图分类号: